# Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase

Study · id `cardio:ct-nct02259738` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02259738](<https://clinicaltrials.gov/study/NCT02259738>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02259738

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

## Technical summary

Registry record NCT02259738. Allocation not applicable; single masking; primary purpose treatment. Start 2013-01 (registry gives no type); primary completion 2014-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 120 participants (enrolled count; ClinicalTrials.gov record NCT02259738, source copy `cardio:ctgov-nct02259738-2014-10-08`, retrieved 2026-10-26)
- Start date: 2013-01 (registry gives no type) (ClinicalTrials.gov record NCT02259738, source copy `cardio:ctgov-nct02259738-2014-10-08`, retrieved 2026-10-26)
- Primary completion: 2014-06 (actual) (ClinicalTrials.gov record NCT02259738, source copy `cardio:ctgov-nct02259738-2014-10-08`, retrieved 2026-10-26)
- Completion: 2014-06 (actual) (ClinicalTrials.gov record NCT02259738, source copy `cardio:ctgov-nct02259738-2014-10-08`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT02259738, source copy `cardio:ctgov-nct02259738-2014-10-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02259738-2014-10-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: Multi-modality MRI Study on Effect to Collateral Circulation and Blood Perfusion of Acute Cerebral Infarction by Human Urinary Kallidinogenase
- Condition: Cerebral Infarction
- Intervention (Drug): Human Urinary Kallidinogenase
- Intervention (Drug): Shuxuening injection
- Lead sponsor: XuanwuH 2
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 8b8e355b8d159ac9e8d9a8a3914827fc685947ff5804e0c0b8ed98000b56e673
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
